explore -WSS

explore

author：fashion 2025-08-11 16:25:04 - browse：6

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Senate panel eyes new effort on drug shortages

WSS

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Analysis of telehealth claims data suggest service duplication

Physician executives need more than on

FDA authorizes Novavax’s updated Covid

Why age limits for politicians are a terrible idea

Physician executives need more than on

Wikipedia

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Liquid biopsy for lung cancer is launched by Delfi

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

New air purifier tech could be key to improving indoor air quality

Wegovy cuts risk of cardiovascular events by 20%, study finds

At least 13 dead in Texas as scorching temps continue

3 questions for the future of Biden's cancer moonshot

In age of alternative facts, a scholarly course on calling out crap

What to expect at HLTH 2023, the health care industry conference

leisure time

Phenylephrine and the overlooked value of the placebo effect

Lessons Learned: This is why you network to find that industry job you want

VC firm General Catalyst wants to buy a health system

Was Amgen transparent enough on FDA's concern on cancer drug?

Why age limits for politicians are a terrible idea

Former Georgia lieutenant governor says he received grand jury subpoena

hotspot

entertainment

focus

entertainment